Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 3, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$167B
sum of reported positions
Reported positions
567
Changes vs prior quarter
589
80 new · 75 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 178 measured positions in 8 quarters, the typical new or larger position finished −2.9 pts against the S&P 500 and 43% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $145B | $167B |
| Positions | 562 | 567 |
| Biggest line | — | NVIDIA 8% |
| 21.4M |
| $8.09B |
| 4.8% |
| 18.8M | $6.72B | 4.0% |
| 5.46M | $6.55B | 3.9% |
| 16.3M | $6.09B | 3.7% |
| 9.97M | $5.79B | 3.5% |
| 10.7M | $5.1B | 3.1% |
| 14M | $4.95B | 3.0% |
| 7.37M | $4.15B | 2.5% |
| 10.9M | $4.08B | 2.4% |
| 8.57M | $3.6B | 2.2% |
| 3.76M | $2.87B | 1.7% |
| 5M | $2.57B | 1.5% |
| 6.93M | $2.38B | 1.4% |
| 18.5M | $2.1B | 1.3% |
| 9.52M | $2.06B | 1.2% |
| 2.17M | $2.03B | 1.2% |
| 27.1M | $1.93B | 1.2% |
| 6.86M | $1.79B | 1.1% |
| 4.5M | $1.69B | 1.0% |
| 9.22M | $1.63B | 1.0% |
| 6.34M | $1.61B | 1.0% |
| 3.53M | $1.53B | 0.9% |
Neurogene (NGNE)
528K → 519K shares (−2%)
Mirion Technologies, Inc. (MIR)
943K → 887K shares (−6%)
Palo Alto Networks (PANW)
48K → 45K shares (−7%)
Lpl Financial (LPLA)
135K → 54K shares (−60%)
Impinj, Inc. (PI)
109K → 106K shares (−3%)
Adaptive Biotechnologies (ADPT)
753K → 686K shares (−9%)
Tyra Biosciences (TYRA)
632K → 451K shares (−29%)
Herc (HRI)
105K → 100K shares (−5%)
Western Midstream Partners, LP (WES)
319K → 313K shares (−2%)
Hess Midstream LP (HESM)
368K → 361K shares (−2%)
Analog Devices (ADI)
95K → 33K shares (−65%)
Rezolute (RZLT)
3.44M → 2.46M shares (−29%)
Kinetik Holdings, Inc. (KNTK)
267K → 262K shares (−2%)
Xenon Pharmaceuticals (XENE)
1.32M → 208K shares (−84%)
TEVA PHARMACEUTICAL INDS LTD
1.44M → 359K shares (−75%)
Servicetitan (TTAN)
380K → 167K shares (−56%)
Penn Entertainment (PENN)
693K → 517K shares (−26%)
Skyward Specialty Insurance Group (SKWD)
422K → 184K shares (−57%)
Mineralys Therapeutics (MLYS)
1.27M → 383K shares (−70%)
Repligen (RGEN)
121K → 75K shares (−38%)
Korn/Ferry International (KFY)
648K → 153K shares (−76%)
Venture Global (VG)
918K → 900K shares (−2%)
Concrete Pumping Holdings (BBCP)
1.48M → 797K shares (−46%)
Exzeo Group (XZO)
575K → 569K shares (−1%)
Prestige Consumer Healthcare (PBH)
207K → 199K shares (−4%)
